Physical Activity During Chemotherapy May Prevent Nerve Damage: JAMA Study Anshika Mishra3 July 2024 8:15 AM ISTCancer treatments often result in nerve damage, leading to long-lasting symptoms for patients. Traditional medications have proven largely ineffective...
Physical exercise may prevent nerve damage during chemotherapy: Study Dr. Kamal Kant Kohli2 July 2024 7:30 AM ISTCancer treatments often cause nerve damage that can lead to long-lasting symptoms. Medication has proven ineffective in these cases. A sports...
Common BP drug may make leukemia more responsive to chemotherapy while protecting heart: Study Dr. Kamal Kant Kohli30 Jun 2024 8:30 PM ISTResearchers from the University of Missouri School of Medicine found that a targeted gene therapy may make acute myeloid leukemia (AML) more sensitive...
AstraZeneca Imfinzi plus chemotherapy gets USFDA nod for mismatch repair deficient advanced or recurrent endometrial cancer Ruchika Sharma17 Jun 2024 11:30 AM ISTCambridge: AstraZeneca has announced that Imfinzi (durvalumab) in combination with carboplatin and paclitaxel followed by Imfinzi monotherapy has...
Cleveland Clinic research findings may lead to improved treatments for chemotherapy-resistant ovarian cancer Dr. Kamal Kant Kohli13 Jun 2024 10:00 PM ISTCleveland Clinic researchers have discovered a new location for a protein that helps ovarian cancer cells resist chemotherapy treatments and that...
AstraZeneca Tagrisso, chemotherapy recommended for approval in EU by CHMP for EGFR-mutated advanced lung cancer Ruchika Sharma5 Jun 2024 2:00 PM ISTCambridge: AstraZeneca's Tagrisso (osimertinib) with the addition of pemetrexed and platinum-based chemotherapy has been recommended for...
Donepezil does not improve chemotherapy-related cognitive impairment: Study Dr. Kamal Kant Kohli21 May 2024 9:15 PM ISTMany breast cancer survivors report cancer-related cognitive impairment following chemotherapy, although prevalence rates and severity vary. To test...
Phase 3 trial evaluating Keytruda in endometrial cancer misses primary survival endpoint: Merck Ruchika Sharma11 May 2024 12:41 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the Phase 3 KEYNOTE-B21 trial evaluating KEYTRUDA,...
Pfizer-Genmab gets full USFDA approval for Tivdak to treat recurrent or metastatic cervical cancer Ruchika Sharma30 April 2024 12:30 PM ISTNew York: Pfizer Inc. and Genmab A/S have announced the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics...
JnJ gets positive CHMP opinion for Rybrevant, chemotherapy combo for first-line treatment of patients with advanced non-small cell lung cancer with activating EGFR exon 20 insertion mutations Ruchika Sharma28 April 2024 12:30 PM ISTBelgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the Committee for Medicinal Products for Human Use...
GSK application for expanded indication of Jemperli plus chemotherapy accepted by USFDA for priority review Ruchika Sharma25 April 2024 12:40 PM ISTLondon: GSK plc has announced the US Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for...
Merck gets Canadian nod for Keytruda in combo with fluoropyrimidine- and platinum-containing-chemotherapy for HER2-negative gastric or gastroesophageal junction adenocarcinoma Ruchika Sharma23 April 2024 3:08 PM ISTKirkland: Merck, known as MSD outside the United States and Canada, has announced that Health Canada has granted approval of KEYTRUDA...
